AllTrials – Transparency index

Company ranking

Rank	Name	Score	Breakdown
1	GlaxoSmithKline	1041	Registration: 15% Summary results: 14% Clinical study reports: 10% Individual patient data: 14%
2	LEO Pharma	1030	Registration: 10% Summary results: 19% Clinical study reports: 13% Individual patient data: 10%
3	Takeda Pharmaceuticals, Inc.	969	Registration: 16% Summary results: 16% Clinical study reports: 8% Individual patient data: 10%
4	Pfizer Inc	892	Registration: 16% Summary results: 8% Clinical study reports: 12% Individual patient data: 9%
5	Novartis Pharmaceuticals Corporation	885	Registration: 17% Summary results: 18% Clinical study reports: 6% Individual patient data: 4%
6	Novo Nordisk A/S	867	Registration: 16% Summary results: 9% Clinical study reports: 9% Individual patient data: 10%
7	Boehringer Ingelheim	819	Registration: 17% Summary results: 11% Clinical study reports: 8% Individual patient data: 5%
8	Amgen Inc	704	Registration: 13% Summary results: 14% Clinical study reports: 5% Individual patient data: 3%
9	Merck & Co.	676	Registration: 13% Summary results: 6% Clinical study reports: 7% Individual patient data: 8%
10	AbbVie	658	Registration: 15% Summary results: 7% Clinical study reports: 2% Individual patient data: 10%
11	Bayer HealthCare LLC	632	Registration: 15% Summary results: 7% Clinical study reports: 6% Individual patient data: 4%
12	Eli Lilly and Company	629	Registration: 11% Summary results: 7% Clinical study reports: 7% Individual patient data: 7%
13	Bristol-Myers Squibb Company	626	Registration: 10% Summary results: 6% Clinical study reports: 7% Individual patient data: 9%
14	Merck KGaA & Merck (EMD) Serono	612	Registration: 11% Summary results: 7% Clinical study reports: 6% Individual patient data: 7%
15	Johnson & Johnson	588	Registration: 14% Summary results: 4% Clinical study reports: 5% Individual patient data: 6%
16	Astellas Pharma	574	Registration: 10% Summary results: 4% Clinical study reports: 6% Individual patient data: 8%
17	Otsuka Pharmaceutical Co., Ltd	518	Registration: 10% Summary results: 8% Clinical study reports: 1% Individual patient data: 7%
18	AstraZeneca Pharmaceuticals LP	513	Registration: 12% Summary results: 9% Clinical study reports: 0% Individual patient data: 4%
19	Daiichi Sankyo, Inc	511	Registration: 10% Summary results: 3% Clinical study reports: 6% Individual patient data: 7%
20	UCB	509	Registration: 14% Summary results: 7% Clinical study reports: 1% Individual patient data: 3%
21	Roche	507	Registration: 0% Summary results: 9% Clinical study reports: 11% Individual patient data: 5%
22	Eisai Inc.	491	Registration: 10% Summary results: 2% Clinical study reports: 5% Individual patient data: 7%
23	Biogen	479	Registration: 10% Summary results: 5% Clinical study reports: 6% Individual patient data: 4%
24	Ipsen	468	Registration: 14% Summary results: 9% Clinical study reports: 0% Individual patient data: 0%
25	Sanofi	464	Registration: 10% Summary results: 4% Clinical study reports: 6% Individual patient data: 4%
26	Lundbeck Inc.	447	Registration: 11% Summary results: 2% Clinical study reports: 6% Individual patient data: 4%
27	Almirall	413	Registration: 14% Summary results: 6% Clinical study reports: 0% Individual patient data: 0%
28	Celgene Corporation	394	Registration: 10% Summary results: 0% Clinical study reports: 6% Individual patient data: 4%
29	PhRMA IFPMA EFPIA JPMA 2005 Joint Position on the Disclosure of Clinical TrialInformation via Clinical Trial Registries and Databases	343	Registration: 14% Summary results: 3% Clinical study reports: 0% Individual patient data: 0%
30	PhRMA IFPMA EFPIA JPMA 2009 update to 2005 Joint Position on the Disclosure of Clinical TrialInformation via Clinical Trial Registries and Databases"	301	Registration: 12% Summary results: 3% Clinical study reports: 0% Individual patient data: 0%
31	Orion Pharma	300	Registration: 10% Summary results: 2% Clinical study reports: 0% Individual patient data: 3%
32	Servier	296	Registration: 15% Summary results: 0% Clinical study reports: 0% Individual patient data: 0%
33	PhRMA "Principles on conduct of clinical trials, communication of clinical trial results." (Updated Dec 2014)	275	Registration: 10% Summary results: 4% Clinical study reports: 0% Individual patient data: 0%
34	Menarini	263	Registration: 10% Summary results: 3% Clinical study reports: 0% Individual patient data: 0%
35	Grunenthal	234	Registration: 0% Summary results: 0% Clinical study reports: 5% Individual patient data: 7%
36	ViiV Healthcare	225	Registration: 0% Summary results: 0% Clinical study reports: 5% Individual patient data: 6%
37	EFPIA/PhRMA "Principles for responsible clinical trial data sharing", 2013	176	Registration: 0% Summary results: 0% Clinical study reports: 5% Individual patient data: 3%
38	Purdue Pharma L.P.	63	Registration: 0% Summary results: 0% Clinical study reports: 0% Individual patient data: 3%
39	Medtronic	38	Registration: 0% Summary results: 2% Clinical study reports: 0% Individual patient data: 0%
40	Abbott	0	Registration: 0% Summary results: 0% Clinical study reports: 0% Individual patient data: 0%
41	Alkermes plc	0	Registration: 0% Summary results: 0% Clinical study reports: 0% Individual patient data: 0%
42	Dainippon Sumitomo Pharma	0	Registration: 0% Summary results: 0% Clinical study reports: 0% Individual patient data: 0%
43	Esteve	0	Registration: 0% Summary results: 0% Clinical study reports: 0% Individual patient data: 0%
44	Gilead	0	Registration: 0% Summary results: 0% Clinical study reports: 0% Individual patient data: 0%
45	Sigma-Tau Pharmaceuticals, Inc.	0	Registration: 0% Summary results: 0% Clinical study reports: 0% Individual patient data: 0%
46	Valeant	0	Registration: 0% Summary results: 0% Clinical study reports: 0% Individual patient data: 0%

+AllTrials Transparency Index

About this site

Company ranking